Alexion's Acquisition of Synageva
Scroll to keep reading
Matthew Hurd, Legal counsel to Synageva
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion’s business in treatments for rare diseases.
Alexion’s takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock.
FinanceThe Covid-19 pandemic has caused immeasurable harm to businesses. However, there are some that are thriving. Find out where best to invest now.
InnovationAt Naprotek, we are focused on solving the biggest challenges in the electronics manufacturing services (EMS) industry.
NewsIf your business doesn't have the resources to handle customer services, outsourcing to another company could be a good idea. Read on to find out more.
FinanceWith a passion for providing its expertise to organisations of all sizes around the world, TaxCoach is a trusted consultancy firm that offers a variety of financial services to help clients succeed in their endeavours.
FinanceHaving female managers on the board improves a company’s share price, according to new research from Skema business school.
NewsThis year’s Q4 report by Canxchange looked at the state and prospects of the global market for hemp products. Canxchange provides industry analyses to professionals in the sector, and in their latest report, they highlighted the role of the industrial use of
M&AThe Clearing House (TCH)has announced it has entered into a letter of intent with VocaLink, the UK-based international payment systems provider.
NewsThe Canadian tax landscape is known for its complexity, with a myriad of rules, regulations, and constant updates that can leave businesses overwhelmed and struggling to navigate through the intricacies of tax compliance. As businesses strive to stay competiti
NewsNearly a third of employees have little understanding of how to use AI and data and less than one in ten have received training on AI tools in the past 12 months
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
